8-K
Current Report
Iambic Therapeutics, Inc. Filed Acc 0001193125-26-424242
Bylaws or fiscal year change · Regulation FD disclosure
- Item 5.03 Amendments to articles or bylaws; change in fiscal year
- Item 7.01 Regulation FD disclosure
From the SEC's structured data for this filing
Loading iam-20261016.htm…